Nektar Therapeutics NKTR reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Nektar Therapeutics beat estimated earnings by 2.47%, reporting an EPS of $-0.79 versus an estimate of $-0.81.
Revenue was up $1.55 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 19.22% drop in the share price the next day.
Here's a look at Nektar Therapeutics's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.8 | -0.74 | -0.72 | -0.68 |
EPS Actual | -0.7 | -0.69 | -0.68 | -0.65 |
Revenue Estimate | 27.87M | 25.98M | 26.90M | 30.01M |
Revenue Actual | 24.92M | 28.33M | 23.65M | 23.46M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.